<SEC-DOCUMENT>0001193125-21-276651.txt : 20210920
<SEC-HEADER>0001193125-21-276651.hdr.sgml : 20210920
<ACCEPTANCE-DATETIME>20210920060641
ACCESSION NUMBER:		0001193125-21-276651
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20210920
FILED AS OF DATE:		20210920
DATE AS OF CHANGE:		20210920

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KAZIA THERAPEUTICS LTD
		CENTRAL INDEX KEY:			0001075880
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-29962
		FILM NUMBER:		211261980

	BUSINESS ADDRESS:	
		STREET 1:		LEVEL 5
		STREET 2:		20 GEORGE STREET
		CITY:			HORNSBY NSW
		STATE:			C3
		ZIP:			2077
		BUSINESS PHONE:		01161298780088

	MAIL ADDRESS:	
		STREET 1:		LEVEL 5
		STREET 2:		20 GEORGE STREET
		CITY:			HORNSBY NSW
		STATE:			C3
		ZIP:			2077

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NOVOGEN LTD
		DATE OF NAME CHANGE:	19981228
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d230301d6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML><HEAD>
<TITLE>FORM 6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.25in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Form 6-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>REPORT OF FOREIGN PRIVATE ISSUER </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO RULE 13a-16 OR 15d-16 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>UNDER THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the month of September, 2021 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Commission File Number
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Kazia
Therapeutics Limited </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Translation of registrant&#146;s name into English) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Three International Towers Level 24 300 Barangaroo Avenue Sydney NSW 2000 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive office) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Form
20-F&nbsp;&nbsp;&#9745;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Form 40-F&nbsp;&nbsp; &#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if
the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note</B>: Regulation S-T Rule
101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by
check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note</B>:
Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which
the registrant is incorporated, domiciled or legally organized (the registrant&#146;s &#147;home country&#148;), or under the rules of the home country exchange on which the registrant&#146;s securities are traded, as long as the report or other
document is not a press release, is not required to be and has not been distributed to the registrant&#146;s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on
EDGAR. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant by furnishing the information contained in this form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes&nbsp;&nbsp;&#9744;&nbsp;&nbsp;&nbsp;&nbsp; No&nbsp;&nbsp;&#9745; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If
&#147;yes&#148; is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b) </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Kazia Therapeutics Limited</B> <B></B>(Registrant) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Kate Hill </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kate Hill </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Company Secretary </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date 20&nbsp;September 2021 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g230301img001.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ASX RELEASE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">20&nbsp;September 2021 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DATE OF AGM AND
CLOSING DATE FOR RECEIPT OF DIRECTOR NOMINATIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sydney, </B><B>20 September 2021</B> &#150; Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA),
an oncology-focused drug development company, is pleased to advise that the Annual General Meeting of the Company will be held on <B>Wednesday 10&nbsp;November 2021</B><B> at 10am Sydney time</B>. Further details will be provided to shareholders and
released to ASX in due course, along with the Notice of Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance with ASX listing rules, valid nominations for the position of director are
required to be lodged at the registered office of the Company by <B>5.00&nbsp;pm (AEST) on</B><B> 29&nbsp;September 2021.</B> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Kazia Therapeutics
Limited </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA) is an oncology-focused drug development company, based in Sydney, Australia. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our lead program is paxalisib, a brain-penetrant inhibitor of the PI3K / Akt / mTOR pathway, which is being developed to treat glioblastoma, the most common
and most aggressive form of primary brain cancer in adults. Licensed from Genentech in late 2016, paxalisib commenced recruitment to GBM AGILE, a pivotal study in glioblastoma, in January 2021. Eight additional studies are active in various forms of
brain cancer. Paxalisib was granted Orphan Drug Designation for glioblastoma by the US FDA in February 2018, and Fast Track Designation for glioblastoma by the US FDA in August 2020. In addition, paxalisib was granted Rare Pediatric Disease
Designation and Orphan Designation by the US FDA for DIPG in August 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kazia is also developing EVT801, a small-molecule inhibitor of VEGFR3, which
was licensed from Evotec SE in April 2021. Preclinical data has shown EVT801 to be active against a broad range of tumour types and has provided compelling evidence of synergy with immuno-oncology agents. A phase I study is expected to begin in
CY2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For more information, please visit <U>www.kaziatherapeutics.com</U> or follow us on Twitter @KaziaTx. This document was authorized for release to
the ASX by James Garner, Chief Executive Officer, Managing Director. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g230301img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g230301img001.jpg
M_]C_X  02D9)1@ ! 0$"6 )8  #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@                  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
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M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
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M# P,# P,# P,#/_  !$( 'L#%P,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0
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MZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /A.BBBON#XL**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1NHHH -U&ZBB@ W4;J** /7_ -@@Y_:_\%_]=+W_ -(+FBD_8'_Y._\ !?\
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MN9=Q\K[&!FC-6-6TF[T#5;JPU"UNK&_L9GM[FVN8FAFMI48J\;HP#*ZL""I
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M<^M,1?+967Y6C^Z1_#SGCTYYXJ/J>EK_ (=[7_*YI]<5[\OX]KV_,_57XF_
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MACQ(N[X$Q6EXP\8:M\0O%NJ:]KVH76K:WK5U)>W][<OOFNYY&+.['U)/;@=
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M-[9_ QY[>XMY#'-;R+H1971ARK*0"".00#7+_P#!,O\ ;5\+_P#!6W]CC6O
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MOAZF*==1J+W.6]]$^:^SLWNNVFGH<WBC%%%<AZ08HQ110 8HQ110 8HQ110
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MRI58WC)6:[I]#U;XI?M?>)?B9\5_#_BSR+'2[CPNP;3K:(-)$AW!G+ECEM^
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HV9KFXT6:.*+=97"+EB,#+,H^I%%?T545SU<QG-W:1T4<#&FK)G__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
